For example, gene therapy using herpes simplex virus TK and canine IFNβ combined with a subcutaneously delivered cellular vaccine expressing human IL-2 and GM-CSF significantly prolonged disease-free and overall survival while maintaining the quality of life of dogs with melanoma 117. This evidence concerns the gene IFNB1 and melanoma.